Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.

摘要

The treatment approach to non Hodgkin lymphoma (NHL) in patients with renal failure is a challenging concern. The case of a dialysed patient, suffering from a splenic marginal zone lymphoma (SMZL) with villous lymphocytes, who received rituximab associated with chlorambucil as first-line treatment is here described